News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
773,344 Results
Type
Article (54379)
Company Profile (302)
Press Release (718662)
Multimedia
Podcasts (87)
Webinars (16)
Section
Business (221200)
Career Advice (2925)
Deals (37701)
Drug Delivery (119)
Drug Development (86836)
Employer Resources (185)
FDA (17293)
Job Trends (16082)
News (373840)
Policy (36074)
Tag
Academia (2925)
Academic (1)
Accelerated approval (10)
Adcomms (30)
Allergies (105)
Alliances (53716)
ALS (119)
Alzheimer's disease (1548)
Antibody-drug conjugate (ADC) (174)
Approvals (17254)
Artificial intelligence (346)
Autoimmune disease (32)
Automation (19)
Bankruptcy (392)
Best Places to Work (12233)
BIOSECURE Act (20)
Biosimilars (132)
Biotechnology (212)
Bladder cancer (98)
Brain cancer (39)
Breast cancer (385)
Cancer (3029)
Cardiovascular disease (236)
Career advice (2462)
Career pathing (33)
CAR-T (198)
CDC (38)
Cell therapy (539)
Cervical cancer (23)
Clinical research (71189)
Collaboration (1080)
Company closure (3)
Compensation (697)
Complete response letters (30)
COVID-19 (2840)
CRISPR (64)
C-suite (355)
Cystic fibrosis (115)
Data (3069)
Decentralized trials (2)
Denatured (24)
Depression (74)
Diabetes (368)
Diagnostics (6858)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (151)
Drug pricing (143)
Drug shortages (31)
Duchenne muscular dystrophy (134)
Earnings (93202)
Editorial (47)
Employer branding (24)
Employer resources (160)
Events (124495)
Executive appointments (904)
FDA (18998)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (985)
Gene editing (141)
Generative AI (28)
Gene therapy (416)
GLP-1 (891)
Government (4977)
Grass and pollen (6)
Guidances (181)
Healthcare (20268)
HIV (43)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (175)
Immuno-oncology (11)
Indications (40)
Infectious disease (3029)
Inflammatory bowel disease (160)
Inflation Reduction Act (11)
Influenza (68)
Intellectual property (123)
Interviews (563)
IPO (17268)
IRA (51)
Job creations (4255)
Job search strategy (2032)
Kidney cancer (15)
Labor market (52)
Layoffs (556)
Leadership (25)
Legal (8991)
Liver cancer (85)
Longevity (12)
Lung cancer (426)
Lymphoma (213)
Machine learning (11)
Management (62)
Manufacturing (411)
MASH (98)
Medical device (14286)
Medtech (14291)
Mergers & acquisitions (21157)
Metabolic disorders (924)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (135)
Neuropsychiatric disorders (39)
Neuroscience (2287)
NextGen: Class of 2025 (7173)
Non-profit (4921)
Now hiring (47)
Obesity (469)
Opinion (275)
Ovarian cancer (103)
Pain (116)
Pancreatic cancer (124)
Parkinson's disease (197)
Partnered (22)
Patents (313)
Patient recruitment (171)
Peanut (55)
People (63214)
Pharmaceutical (68)
Pharmacy benefit managers (23)
Phase I (22106)
Phase II (31189)
Phase III (23354)
Pipeline (1683)
Policy (229)
Postmarket research (2966)
Preclinical (9531)
Press Release (71)
Prostate cancer (148)
Psychedelics (46)
Radiopharmaceuticals (269)
Rare diseases (509)
Real estate (6612)
Recruiting (73)
Regulatory (24777)
Reports (51)
Research institute (2587)
Resumes & cover letters (458)
Rett syndrome (10)
RNA editing (9)
RSV (54)
Schizophrenia (97)
Series A (168)
Series B (115)
Service/supplier (15)
Sickle cell disease (66)
Special edition (20)
Spinal muscular atrophy (160)
Sponsored (35)
Startups (3927)
State (2)
Stomach cancer (17)
Supply chain (81)
Tariffs (63)
The Weekly (61)
Vaccines (875)
Venture capital (56)
Weight loss (301)
Women's health (48)
Worklife (19)
Date
Today (94)
Last 7 days (380)
Last 30 days (1929)
Last 365 days (32633)
2025 (17663)
2024 (36871)
2023 (41851)
2022 (53156)
2021 (57859)
2020 (56709)
2019 (49914)
2018 (37817)
2017 (34756)
2016 (34879)
2015 (41055)
2014 (35374)
2013 (30825)
2012 (32824)
2011 (33433)
2010 (31843)
Location
Africa (943)
Alabama (64)
Alaska (7)
Arizona (263)
Arkansas (14)
Asia (43342)
Australia (7801)
California (7635)
Canada (2400)
China (707)
Colorado (331)
Connecticut (336)
Delaware (200)
Europe (96445)
Florida (1138)
Georgia (260)
Hawaii (1)
Idaho (63)
Illinois (683)
India (30)
Indiana (373)
Iowa (17)
Japan (235)
Kansas (111)
Kentucky (31)
Louisiana (15)
Maine (73)
Maryland (1065)
Massachusetts (5778)
Michigan (270)
Minnesota (477)
Mississippi (3)
Missouri (97)
Montana (32)
Nebraska (25)
Nevada (81)
New Hampshire (71)
New Jersey (2149)
New Mexico (30)
New York (2137)
North Carolina (1187)
North Dakota (10)
Northern California (3342)
Ohio (245)
Oklahoma (16)
Oregon (37)
Pennsylvania (1639)
Puerto Rico (18)
Rhode Island (38)
South America (1323)
South Carolina (35)
South Dakota (1)
Southern California (2852)
Tennessee (129)
Texas (1157)
United States (28630)
Utah (226)
Virginia (195)
Washington D.C. (77)
Washington State (659)
West Virginia (4)
Wisconsin (71)
773,344 Results for "prophase labs inc formerly known as quigley corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
June 26, 2025
·
5 min read
Press Releases
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025
May 14, 2025
·
2 min read
Press Releases
ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer
June 17, 2025
·
6 min read
Press Releases
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
April 1, 2025
·
21 min read
Press Releases
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
May 20, 2025
·
23 min read
Press Releases
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
March 28, 2025
·
1 min read
Press Releases
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
June 6, 2025
·
6 min read
Press Releases
ProPhase Labs to Present at the Investor Summit Virtual on March 11
March 10, 2025
·
1 min read
Business
Prophase Labs Inc. To Present First Quarter 2024 Financial Results on May 9
ProPhase Labs Inc., announced that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT.
May 2, 2024
·
1 min read
Press Releases
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports
February 18, 2025
·
9 min read
1 of 77,335
Next
